| Literature DB >> 35581699 |
Astrid Herzum1, Martina Burlando1, Pietro Paolo Tavilla1, Claudia Micalizzi1, Mattia Fabio Molle1, Emanuele Cozzani1, Aurora Parodi1.
Abstract
BACKGROUND: Basal cell carcinoma (BCC) can cause extensive tissue damage if untreated. Complete surgical excision is the treatment of choice, but especially in the head-and neck area, defining both radical and healthy skin sparing surgical margins is complex.Entities:
Mesh:
Year: 2022 PMID: 35581699 PMCID: PMC9321004 DOI: 10.1111/ddg.14757
Source DB: PubMed Journal: J Dtsch Dermatol Ges ISSN: 1610-0379 Impact factor: 5.231
Figure 1Basal cell carcinoma of the nose (control, only clinically evaluated): surgical safety margins at 1.5 mm are outlined by blue dots (a). Clinically evaluated surgical margins at 1.5mm (blue dots) and surgical planning (blue full line) (b).
Figure 2Basal cell carcinoma of the forehead (control, only clinically evaluated): surgical safety margins at 3 mm are displayed by light‐blue dots (a). Clinically evaluated surgical margins at 3 mm overwritten by surgical planning, in light‐blue full line (b).
Figure 3Basal cell carcinoma of the nose (case): surgical safety margins at 1.5 mm were at first clinically evaluated and outlined by blue dots (a). Clinically evaluated surgical margins at 1.5 mm (blue dots) and dermatoscopically evaluated margins at 1.5 mm (blue full line) (b).
Figure 4Preauricular basal cell carcinoma (case): surgical safety margins at 3 mm were at first clinically evaluated and displayed by black dots (a). Clinically evaluated surgical margins at 3 mm (black dots) and dermatoscopically evaluated margins at 3 mm (blue full line) (b).
Clinical subtype and anatomical distribution of excised BCCs in cases and controls
| Nodular BCC % (cases n, controls n) | Superficial BCC % (cases n, controls n) | Total BCC n° or % (cases n, controls n) | Chi square test | |
|---|---|---|---|---|
| Total | 76 % (103, 111) | 24 % (36, 31) | 281 (139, 142) |
0.42 Cases vs. controls compared for BCC type (nodular vs. superficial) |
| Face | 67 % (68, 75) | 30 % (7, 13) | 58 % (75, 88) | < 0.001* (nodular vs. superficial BCCs, in both cases and controls, compared for face vs. all other locations) |
| Scalp | 11 % (11, 12) | 7 % (4, 1) | 10 % (15, 13) | 0.61 (nodular vs. superficial BCCs, in both cases and controls, compared for scalp vs. all other locations) |
| Neck | 22 % (24, 24) | 63 % (25, 17) | 32 % (49, 41) |
< 0.001 *(nodular vs. superficial BCCs, in both cases and controls, compared for neck vs. all other locations) |
*Statistically significant.
Width and properness of lateral and deep surgical margins, in cases and controls
| Cases | Controls | Chi square test | |||
|---|---|---|---|---|---|
| Unproper margins | Proper margins | Unproper margins | Proper margins | ||
| Lateral margins | 4 % (5/139) | 96 % (134/139) | 20 % (29/142) | 80 % (113/142) | < 0.001* |
| – 3 mm | 0 % (0/66) | 100 % (66/66) | 15 % (10/66) | 85 % (56/66) | 0.0014* |
| – 1 mm to 2 mm | 7 % (5/73) | 93 % (68/73) | 25 % (19/76) | 75 % (57/76) | 0.003* |
| Deep margins | 6 % (8/139) | 94 % (131/139) | 8 % (12 /142) | 92 % (130/142) | 0.49 |
*Statistically significant.
Anatomic distribution of facial BCCs in cases and controls and respective unproper surgical lateral margins
| Cases n (unproper lateral margins n, %) | Controls n (unproper lateral margins n, %) | Total n (unproper lateral margins n, %) | Chi square test | |
|---|---|---|---|---|
| Lip | 4 (0; 0 %) | 4 (3; 75 %) | 8 (3; 38 %) | 0.14 |
| Temple‐preauricular | 9 (1; 11 %) | 16 (6; 38 %) | 25 (7; 28 %) | 0.35 |
| Eyelid | 4 (1; 25 %) | 7 (1; 14 %) | 11 (2; 18 %) | 1 |
| Cheek | 13 (1; 8 %) | 22 (3; 14 %) | 35 (4;11 %) | 1 |
| Nose | 14 (0; 0 %) | 14 (3; 21 %) | 28 (3; 11 %) | 0.2 |
| Mandible | 11 (1; 9 %) | 4 (0; 0 %) | 15 (1; 7 %) | 1 |
| Ear | 5 (0; 0 %) | 4 (0; 0 %) | 9 (0; 0 %) | N/A |
| Forehead | 15 (0; 0 %) | 17 (0; 0 %) | 32 (0; 0 %) | N/A |
Abbr.: N/A, not applicable.